Can preprotein be administered to a patient with end-stage renal disease undergoing hemodialysis (HD) and a history of hypertension and diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Preprotein Be Administered to Patients with HD?

Yes, protein supplementation can and should be administered to hemodialysis patients, particularly those with evidence of malnutrition or inadequate dietary intake, with a target dietary protein intake of 1.0-1.2 g/kg body weight per day. 1

Protein Requirements for Hemodialysis Patients

Hemodialysis patients require higher protein intake than the general population due to dialysis-related protein losses and increased catabolism. The evidence consistently supports this approach:

  • The 2020 KDOQI guidelines recommend prescribing 1.0-1.2 g/kg body weight per day of dietary protein for metabolically stable adults on maintenance hemodialysis to maintain stable nutritional status. 1
  • This recommendation applies to both diabetic and non-diabetic HD patients, though diabetic patients may require higher protein intake to maintain glycemic control. 1
  • Each hemodialysis session removes approximately 10-12 grams of amino acids, necessitating higher dietary protein intake to compensate for these losses. 1

When Protein Supplementation Is Indicated

Oral protein-energy supplementation should be provided when patients cannot meet 70% of their protein requirements through regular diet alone:

  • Patients at risk of or with protein-energy wasting should receive oral nutritional supplements (ONS). 1
  • Evidence from multiple RCTs demonstrates that ONS improves serum albumin, transthyretin (prealbumin), and survival rates in malnourished hemodialysis patients. 1
  • The increase in transthyretin during ONS is independently associated with better survival, regardless of inflammatory status. 1

Monitoring Nutritional Status

Use serum prealbumin (transthyretin) levels ≥30 mg/dL as a target when monitoring nutritional status in HD patients. 1

  • Low predialysis serum creatinine (<10 mg/dL) suggests decreased skeletal muscle mass and/or low dietary protein intake, warranting evaluation for protein-energy malnutrition. 1
  • Serum creatinine and creatinine index are valid markers of protein-energy nutritional status and predict mortality in HD patients. 1

Special Considerations for Acutely Ill HD Patients

For hospitalized or acutely ill hemodialysis patients, protein requirements increase to 1.2-1.3 g/kg/d or higher:

  • Acutely ill hospitalized HD patients often ingest less than recommended amounts and are usually in negative nitrogen balance. 1
  • Protein intakes of 1.3 g/kg/d or greater with adequate energy intake (30-35 kcal/kg/d) improve biochemical markers of nutritional status in hospitalized dialysis patients. 1
  • Patients receiving more intensive dialysis (>3 times per week or continuous venovenous hemofiltration) may tolerate and require protein intakes exceeding 1.3 g/kg/d due to increased amino acid losses. 1

Alternative Routes When Oral Intake Is Inadequate

When oral intake fails to meet requirements despite counseling and ONS, consider intradialytic parenteral nutrition (IDPN):

  • IDPN is specifically indicated for malnourished HD patients who fail to respond to or cannot tolerate oral nutritional supplements or enteral nutrition. 1
  • Multiple RCTs show nutritional improvements with IDPN in HD patients with overt protein-energy wasting. 1
  • IDPN should not be used as first-line therapy before attempting dietary counseling and ONS. 1

Critical Pitfalls to Avoid

  • Do not restrict protein in hemodialysis patients—this is appropriate only for CKD stages 3-5 not yet on dialysis (0.55-0.60 g/kg/d). 1
  • Inadequate protein intake (<1.0 g/kg/d) in HD patients is associated with increased mortality, hypoalbuminemia, and prolonged hospital stays. 1
  • Energy intake must be adequate (25-35 kcal/kg/d) for protein supplementation to be effective; protein alone without sufficient calories leads to protein catabolism for energy. 1
  • In diabetic HD patients with hypertension, monitor for hypoglycemia when increasing protein intake, as improved nutritional status may alter insulin requirements. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

How to manage hypotension in patients with End-Stage Renal Disease (ESRD)?
In a 50-year-old man with advanced chronic kidney disease, uremic peripheral neuropathy, severe microcytic anemia, and mild hyperkalaemia, what is the most appropriate next step in management?
What medications and lab monitoring are recommended for a patient with End-Stage Renal Disease (ESRD), diabetes, Hypertension (HTN), and dyslipidemia?
What is the recommended approach for gradual adjustment of antihypertensive medications in patients with chronic kidney disease on hemodialysis?
What antibiotic regimen is recommended for a 58-year-old male with a history of Diabetes Mellitus (DM) on insulin, End-Stage Renal Disease (ESRD) on Hemodialysis (HD), presenting with fever and hyperlactatemia, and a chronic foot wound previously treated with cephalexin (Cefalexin) and doxycycline (Doxycycline)?
What are the next steps for treatment in an elderly patient with a history of failed sertraline (Selective Serotonin Reuptake Inhibitor) trial for depression?
What are the implications and management of elevated renin levels in an adult patient with a history of hypertension or kidney disease?
Is honey and lemon in hot water a safe and effective treatment for a pregnant woman with a cough due to an upper respiratory tract infection?
Can antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), help manage depression in patients with nutritional deficiencies, particularly those with a history of gastrointestinal disorders or eating disorders?
Is Questran (cholestyramine) powder effective for treating capecitabine-induced diarrhea?
What is the initial treatment for a patient with sialadenitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.